AAAAAA

   
Results: 1-17 |
Results: 17
Advantages of exercise echocardiography in comparison to dobutamine echocardiography in the diagnosis of coronary artery disease in hypertensive subjects
Authors: Pasierski, T Szwed, H Malczewska, B Firek, B Kosmicki, M Rewicki, M Kowalik, I Sadowski, Z
Citation: T. Pasierski et al., Advantages of exercise echocardiography in comparison to dobutamine echocardiography in the diagnosis of coronary artery disease in hypertensive subjects, J HUM HYPER, 15(11), 2001, pp. 805-809
Effect of biosorption of Pb(II), Cu(II) and Cd(II) on the zeta potential and flocculation of Nocardia sp.
Authors: Sadowski, Z
Citation: Z. Sadowski, Effect of biosorption of Pb(II), Cu(II) and Cd(II) on the zeta potential and flocculation of Nocardia sp., MINER ENG, 14(5), 2001, pp. 547-552
Effect of polymer-surfactant adsorption on the hindered settling of a mineral suspension
Authors: Sadowski, Z Polowczyk, I
Citation: Z. Sadowski et I. Polowczyk, Effect of polymer-surfactant adsorption on the hindered settling of a mineral suspension, ADSORPT S T, 19(3), 2001, pp. 245-254
Teh electrical conductivity of mineral suspensions during the sedimentation
Authors: Polowczyk, I Sadowski, Z
Citation: I. Polowczyk et Z. Sadowski, Teh electrical conductivity of mineral suspensions during the sedimentation, INZ CHEM PR, 22(3D), 2001, pp. 1175-1180
The effect of size distribution of aresenic bearing waste on the biooxidation kinetics
Authors: Jazdzyk, E Sadowski, Z
Citation: E. Jazdzyk et Z. Sadowski, The effect of size distribution of aresenic bearing waste on the biooxidation kinetics, INZ CHEM PR, 22(3C), 2001, pp. 561-566
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction
Authors: Llevadot, J Giugliano, RP Antman, EM Wilcox, RG Gurfinkel, EP Henry, T McCabe, CH Charlesworth, A Thompson, S Nicolau, JC Tebbe, U Sadowski, Z Braunwald, E
Citation: J. Llevadot et al., Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction, EUR HEART J, 22(22), 2001, pp. 2104-2115
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
Authors: Bacquet, P Levy, E McGuire, A McMurray, J Merot, JL Paschen, B Remme, WJ Szucs, TD Klein, W Brunhuber, W Hofmann, R Kuhn, P Nesser, HJ Slany, J Weihs, W Wiedermann, C Wimmer, H van Mieghem, W Boland, J Chaudron, JM Jordaens, L Melchior, JP Aschermann, M Bruthansl, J Hradec, M Kolbel, F Semrad, B Haghfelt, T Hansen, JF Goetzsche, CO Hildebrandt, P Kassis, E Rasmussen, V Rokkedal, J Thomassen, A Groundstroem, K Uusimaa, P Le Heuzey, JY Aumont, MC Aupetit, JF Baille, N Baudouy, P Belin, A Bonneau, A Bonneric, G Bousser, JP Citron, B Dary, P Decoulx, E De Groote, P Denolle, T Dievart, F Duriez, P Eicher, JC Enjuto, G Ferriere, M Fournier, E Garandeau, M Gauthier, J Genest, M Gerbe, A Godenir, JP Guillot, B Guillot, JP Guillot, P Heno, P d'Ivernois, C Jean, M Kacet, S Kalle, R Komajda, M Lacroix, A Lallemand, R Lardoux, H Marquet, M Martin, M Martin, O Mery, D Mossaz, R Mothes, P Olive, T Ostorero, M Paganelli, F Page, E Pauly-Laubry, C Puel, J Rousseau, JF Roux, JJ Schenowitz, A Sourdais, K Tremel, F Verdun, A Witchiz, S Wolf, JE Hombach, V Assmann, I Beyer, T Bischoff, KO Darius, H Ertl, G Fleck, E Forster, K Freytag, F Gleichmann, U Haasis, R Henssge, R Hey, D Hesse, P Hofs, T Keck, M Klein, H Kromer, ET Kruls-Munch, J Luderitz, B Maisch, B Mitrovic, V Neubauer, S Osterziel, KJ Simon, H Spitzer, SG Stohring, R Taubert, G Teichmann, W Theisen, K Wende, W Wieser, H Zotz, R Bridges, A Adgey, J Ambepitiya, G Boon, N Boyle, RM Cowley, AJ Cripps, T Davies, MK Dunn, F Findlay, J Forsey, P Fyfe, T Gould, B Greenwood, TW Hubner, P Khan, S Lewis, P Mackay, A Maltz, M McArthur, J McLeod, A McLeod, D Metcalfe, M Millar-Craig, M Mills, P Nelson, JK Nicholls, D Oakley, GD Patterson, DLH Pohl, JEF Ray, S Silke, B Wilkinson, PR Preda, I Csanady, M Cserhalmi, L Edes, I Gesztesi, T Karpati, P Simon, K Tarjan, J Fogari, R Tramarin, R Galie, N Giani, P Milanese, U Scalvini, S Scrutinio, D Sechi, LA Tettamanti, F De Vito, F Crean, P McCann, H Mulcahy, D Sugrue, D van Hoogenhuyze, DCA van der Burgh, PH Ciampricotti, R van Dantzig, JM DenHartog, FR Henneman, JA van Kesteren, HAM Kragten, JA Liem, KL Limburg, A van der Linde, MR Linssen, GCM Pasteuning, H Penn, HJAM Van Rossum, P Schaafsma, HJ Schelling, A Sloos, R Wesdorp, JCL Korewicki, J Achremczyk, P Czestockowska, E Dowgird, M Dyduszynski, A Gorski, J Ilmurzynska, K Janicki, K Kornacewicz-Jach, Z Kraska, T Krzeminska-Pakula, M Kuch, J Nartowicz, E Petelenz, T Piwowarska, W Rawczynska-Englert, I Ruzyllo, W Swiatecka, G Tendera, M Wierzchowiecki, M Wodniecki, J Wojciechowoski, D Wrabec, K Wysocki, H Gomes, RS Ceia, MF Lousada, N Campos, JMM Providencia, LA de Moura, ALZC Marejev, VJ Aronov, DM Arutjunov, GP Bart, BJ Basechikin, SS Belenkov, JN Beloussov, JB Bokeria, OA Charchogljan, RA Doschytsin, V Fedorova, TA Glezer, MG Gorbachenkov, A",Gorshkov,"Gospodarenko, AL Ivashkin, VT Ivleva, AJ Kyrichenko, AA Lavrov, AA Lazebnik, LB Marynov, A Mazaev, VP Polejev, NR",Shpektor,"Sidorenko, BA Sobolev, KE Starodoubtsev, AK Storozhakhov, GI Syrkin, AL Zodionchenko, VS Zvereva, TV Murin, J Kaliska, G Rybar, R Valle, V Artaza, M Conthe, P Cruz, JM Garcia-Moll, M Lopez-Sendon, JL Martinez, A Monzon, F Ribas, M Roig, E Roldan, I Hoglund, C Ekdahl, S Hjelmaeus, L Lindberg, K Lofdahl, P Ulvenstam, G Warselius, L Follath, F Anghern, W Dubach, P Erne, P Gallino, A Moccetti, T Jmouro, AV Dargie, HJ Erdmann, E Follath, F Hoglund, C Lechat, P Sendon, JLL Mareyev, V Remme, WJ Sadowski, Z Seabra-Gomes, RJ Zannad, F Wehrlen-Grandjean, M Funck-Brentano, C Hansen, S Hohnloser, S Vanoli, E Jaillon, P De Baker, G Dahlstrom, U Hill, C Leizorovicz, A Burgnard, F Rolland, C Wiemann, H Verkenne, P Arab, T Cussac, N Dussous, V Haise, S Funck-Brentano, C
Citation: P. Bacquet et al., Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II), EUR HEART J, 22(12), 2001, pp. 1021-1031
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial
Authors: Topol, EJ Califf, RM Van de Werf, F Willerson, JT Booth, J White, H Clayman, M Deckelbaum, L Lincoff, AM Ohman, EM Bates, E Gibler, WB Hochman, J Kleiman, N Grinfeld, L Aylward, P Armstrong, PW Heikkila, J Vahanian, A Steg, G Bode, C Adgy, AAJ Guetta, V Ardissino, D Savonitto, S Bar, F Simoons, M Kontny, F White, H Sadowski, Z Seabra-Gomes, R Dalby, A Betriu, A Swahn, E Wilcox, R Frye, RL Bertrand, ME DeMets, D Fox, KKA Fuster, V Lee, KL McCarthy, C Waller, M Scherer, J van de Kerkhove, A Kukulewicz, L Booth, JE Del Valle, M Hibert, D Brannon, D
Citation: Ej. Topol et al., Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial, LANCET, 357(9272), 2001, pp. 1905-1914
Anti-ischaemic efficacy and tolerability of trimetazidine in elderly patients with angina pectoris - A sub-study from TRIMPOL-1 (trimetazidine in Poland)
Authors: Szwed, H Sadowski, Z Pachocki, R Domzal-Bochenska, M Malczewska, B Jedrzejczyk, B Kania, G Powala, D Hulok, W Kowalisko, A Kulczuga-Kaczmarek, K Grzelak-Szczepanska, H Michalak, J Dabrowski, R Tykarski, A
Citation: H. Szwed et al., Anti-ischaemic efficacy and tolerability of trimetazidine in elderly patients with angina pectoris - A sub-study from TRIMPOL-1 (trimetazidine in Poland), CLIN DRUG I, 19(1), 2000, pp. 1-8
The role of surfactant salts on the spherical agglomeration of hematite suspension
Authors: Sadowski, Z
Citation: Z. Sadowski, The role of surfactant salts on the spherical agglomeration of hematite suspension, COLL SURF A, 173(1-3), 2000, pp. 211-217
Intravenous NPA for the treatment of infarcting myocardium early - InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
Authors: Braunwald, E Neuhaus, KL Antman, E Chew, P Skene, A Wilcox, R Ambrosioni, E Anderson, J Apetrei, E Bata, I Carrageta, M Col, J Dalby, A Davies, R Deckers, J Eichman, D Grande, P Greene, R Gurfinkel, E Heikkila, J Henry, T Hillis, D Hochman, J Huber, K Kostis, J Klinke, P Lopez-Sendon, J McKendall, G Moller, B Moore, P Morris, A Mueller, H Ostor, E Oto, A Ruda, M Sadowski, Z Schweiger, M Sequeira, R Shah, P Shannon, R Smith, B Sobel, B Steingart, R Tebbe, U Toman, J Traboulsi, M Vahanian, A Warnica, JW Willerson, J Deitchman, D Davidson, L Folgia, T Foxley, A Goodman, J Hauck, C Henry, D McCabe, C Pangerl, A Thomson, A Wagner, M Kennedy, JW Cairns, J DeMets, D Julian, D Simoons, M Charlesworth, A Henry, D Skene, A Easton, JD Ferbert, A Feske, S Kuhn, P Moseley, J Rogg, JM Reichmann, H Sloan, M von Kummer, R Zamani, A Antman, E Coulter, S Giugliano, R Wilcox, R
Citation: E. Braunwald et al., Intravenous NPA for the treatment of infarcting myocardium early - InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction, EUR HEART J, 21(24), 2000, pp. 2005-2013
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial
Authors: Topol, CE Califf, RM Simes, RJ Van de Werf, F Diaz, R Paolasso, E Aylward, PE Keech, A Klein, W Piegas, L Tomov, I Armstrong, PW Widimsky, P Grande, P Halinen, M Vahanian, A Neuhaus, K Dimas, AP Preda, I Kristinsson, A Tzivoni, D Ardissino, D White, HD Madsen, S Sugrue, D Sadowski, Z Seabra-Gomes, R Apetrei, E Dalby, A Betriu, A Pfisterer, M Verheugt, F Fox, K Bates, ER Gibler, WB Granger, CB Harrington, RA Hochman, JS Holmes, DR Kleiman, NS Lee, KL Moliterno, DJ Newby, LK Ohman, EM Califf, R Newby, K Zillman, L Lee, K Lemons, P McCourt, B Campbell, C Tardiff, B Snapp, J Bassett, K Hodgson, P Hannan, K Kandzari, L Hawkins, S Hinman-Smith, E McDougal, M Raffetto, K Thompson, D Wehrle, T Ange, C Brown, R Grissom, G Heuckel, M McCall, J Pennachi, W Spychala, M Veasey, S Pullium, M Journey, T Quintero, K Mark, D Davidson-Ray, L Diner, L Nelson, C Sowers, C Webb, G Young, M Bhapkar, M Pacchiana, C Sparapani, R Tuttle, R Weaver, D Borzak, S Douthat, L Topol, E Moliterno, D Konczos, L Baishnab, R Baishnab, R Bakos, A Blashford, L Bratsch, J Brown, K Cadorini, E Carlson, J Clemmons, P DelValle, M Drabik, M Fu, G Gates, K Gibson, Y Heil, L Hill, N Klancar, R McHale, B Montague, E Pasca, N Pergi, L Randall, R Rosso, R Sankovich, K Smith, D Wisniewski, L Witkowski, M Zovkic, V Alexander, K Bhatt, D Brener, S Campbell, L Cho, L Cole, C Deedy, M Foody, J Gassler, J Ghaffari, S Haas, G Kapadia, S Lauer, M Lauer, MS Lincoff, M Lutton, S Marso, S Mukherjee, D Patel, V Penn, M Robbins, M Roe, M Sila, C Thamilarasan, M Wagner, G Armstrong, P Bestilny, S Van de Werf, F Budts, W Graux, S Luyten, A Simes, J Keech, A Kava, M Bower, T Chan, S Crampton, L Monro, C Nayak, M Parente, G Riley, V Wilton, D Aylward, P Dolan, S Thomas, C White, H Scott, M Frye, R Alpert, J Bertrand, M Ryan, T Fisher, L Asarch, L Smith, M Lim, L Bokslag, M Chiu, P Chung, J Collins, S Dougherty, C Guimaraes, D Hakim, Z Mathieson, J Montgomery, L Novotny, B Steiner, B Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345
A randomised comparison of elective high-pressure stenting with balloon angioplasty: Six-month angiographic and two-year clinical follow-up
Authors: Witkowski, A Ruzyllo, W Gil, R Gorecka, B Purzycki, Z Kosmider, M Polonski, L Lekston, A Gasior, M Zmudka, K Pieniazek, P Buszman, P Drzewiecki, J Ciecwierz, D Sadowski, Z
Citation: A. Witkowski et al., A randomised comparison of elective high-pressure stenting with balloon angioplasty: Six-month angiographic and two-year clinical follow-up, AM HEART J, 140(2), 2000, pp. 264-271
Proposed antiischemic effects of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1
Authors: Szwed, H Sadowski, Z Pachocki, R Domzat-Bochenska, M Szymczak, K Szydlowski, Z Paradowski, A Gajos, G Kaluza, G Kulon, I Wator-Brzezinska, A Elikowski, W Kuzniak, M
Citation: H. Szwed et al., Proposed antiischemic effects of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1, CARDIO DRUG, 13(3), 1999, pp. 217-222
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome)
Authors: Guerrero, RAA Amuchastegui, M Badaracco, J Elizari, M Martellotto, R De la Hoz, RP Ramos, JL Salvati, AM Sinisi, A Torre, H Aroney, G Campbell, T Garrahy, P",Lalman,"Liebens, I Renard, M Bastecky, J Bocek, P Cepelak, V Dvorak, K Gregor, J Janousek, S Jansky, P Jirmar, R Kamenik, L Rybka, J Spacek, R Spinar, J Svitil, P Zeman, K Alagha, Z Allam, S Barnay, C Baudouy, M Beltran, J Berland, J Berthou, JD Bery, E Bessede, G Beygui, F Bickert, P Boshat, J Boulenc, JM Bourlard, P Bouthillier, D Brandt, C Cattan, S Charbonnier, B Citron, B Coisne, D Coupillaud, J Da Costa, A Dambrine, P Danchin, N Delarche, N Dequeker, JL Desjouaux, E Dievart, F Dujardin, JJ Durand, P Fadel, N Fichter, P Galinier, M Gryman, R Gauthier, J Geslin, P Godard, S Grollier, G Guerot, C Gully, C Janin-Manificat, L Joly, P Joseph, T Juillard, A Ketelers, JY Lagorce, P Laine, E Lang, M Lanney-Courten, JE Le Helloco, A Ledru, F Levy, S Litvine-Itaya, L Lopez, M Mansour, M Mathurin, C Meyer, G Mossaz, R Nedelec, G Ollitrault, J Pacouret, G Perchet, H Poitrineau, O Richard, M Rocher, R Rougier, L Sagnol, P Tardieu, A Thery, C Thieuleux, F Touboul, P Tran-Tanh, X Veyrat, A Villarem, D Werquin, S Skoufas, P Fotiadis, I Xenodochidis, C Karidis, K Limberi, S Papasteriadis, E Giokas, K Kremastinos, D Polichronaki, E Moshos, N Daskalakis, I Janecsko, M Janosi, A Kalo, E Karpati, P Mezofi, M Nyaradi, A Ofner, P Oze, B Poor, F Preda, I Ronaszeki, A Valyi, P Zamolyi, K Davini, P Martines, C Melandri, F Pasotti, C Pettinati, G Veze, I Kochkarev, F Erpelding, J Halaczkiewicz, H Ilmuzynska, K Kurowski, M Lasota-Czopnik, A Markiewicz, M Musial, W Nartowicz, E Pasyk, S Prastowski, W Ruszkowski, J Sadowski, Z Sas, M Stopinski, M Ujda, M Wojciechowski, D Diniz, M Drumond, A Rodrigues, P Pereira, MA Correia, A Scherbak, A Irklienko, K Dudko, L Goloschekin, B Maximova, G Sorokin, L Inyushin, A Bzhelianskaia, V Kostenko, V Stefanenko, M Bilich, A Froufe, G Masip, J Pajaron, A Roura, J Sanz, G Valle, V Caduff, B Moccetti, T Noseda, G Simonin, C Baars, HF Bernink, PJLM Daniels, MCG Gobel, E Nagelsmit, MJ Ramdat, AR Senden, PJ van Rossum, P van Wijk, LM Withagen, AJAM Crowe, PF Davidson, C Handler, CE",McNeil,"Molajo, AO
Citation: Raa. Guerrero et al., Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome), EUR HEART J, 20(21), 1999, pp. 1553-1562
Ice/water interface: Zeta potential, point of zero charge, and hydrophobicity
Authors: Drzymala, J Sadowski, Z Holysz, L Chibowski, E
Citation: J. Drzymala et al., Ice/water interface: Zeta potential, point of zero charge, and hydrophobicity, J COLL I SC, 220(2), 1999, pp. 229-234
Prophylactic lidocaine use in acute myocardial infarction: Incidence and outcomes from two international trials
Authors: Alexander, JH Granger, CB Sadowski, Z Aylward, PE White, HD Thompson, TD Califf, RM Topol, EJ
Citation: Jh. Alexander et al., Prophylactic lidocaine use in acute myocardial infarction: Incidence and outcomes from two international trials, AM HEART J, 137(5), 1999, pp. 799-805
Risultati: 1-17 |